Target Price | JPY4,718.82 |
Price | JPY4,271.00 |
Potential |
10.49%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Takeda Pharmaceutical 2025 .
The average Takeda Pharmaceutical target price is JPY4,718.82.
This is
10.49%
register free of charge
JPY5,900.00
38.14%
register free of charge
JPY4,200.00
1.66%
register free of charge
|
|
A rating was issued by 18 analysts: 9 Analysts recommend Takeda Pharmaceutical to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Takeda Pharmaceutical stock has an average upside potential 2025 of
10.49%
register free of charge
|
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion JPY | 4,263.76 | 4,428.11 |
5.87% | 3.85% | |
EBITDA Margin | 29.51% | 26.81% |
10.15% | 9.14% | |
Net Margin | 3.39% | 2.69% |
57.42% | 20.62% |
16 Analysts have issued a sales forecast Takeda Pharmaceutical 2025 . The average Takeda Pharmaceutical sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Takeda Pharmaceutical EBITDA forecast 2025. The average Takeda Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Takeda Pharmaceutical Analysts have issued a net profit forecast 2025. The average Takeda Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share JPY | 92.09 | 75.90 |
54.92% | 17.58% | |
P/E | 56.27 | |
EV/Sales | 2.58 |
9 Analysts have issued a Takeda Pharmaceutical forecast for earnings per share. The average Takeda Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Takeda Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Takeda Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.